Viz.ai Partners with Hyperfine to Enable New MR Imaging and Workflow Paradigm
Viz.ai announced today it is partnering with Hyperfine, Inc., creator of the first FDA-cleared point-of-care magnetic resonance imaging (MRI) device,...
Jul 26, 2022
All Resources
Explore our latest resources
Contrast Shortage: How to move forward and continue to provide the best patient...
Explore imaging trends in the acute stroke setting across 1000 hospitals in the US to understand the impact of the...
Jul 13, 2022
March 21, 2022
Viz.ai Neurovascular Impact Continues to Expand
Our latest blog focuses on the expansion of the neurovascular platforms with articles on the latest data from ISC 2022,...
Mar 15, 2022
Viz.ai Receives FDA 510(k) Clearance for Viz™ ANEURYSM (ANX)
Viz.ai, the world leader in artificial intelligence (AI) powered care coordination, today announced it has received U.S. Food and Drug...
Feb 24, 2022
New Data Presented at ISC 2022 Further Validates Impact of the Viz™ Platform...
Data from several new studies presented this week at the International Stroke Conference (ISC) further validates the best-in-class sensitivity and...
Feb 11, 2022
Viz.ai and TeleSpecialists Announce Strategic Partnership
Viz.ai and TeleSpecialists, LLC have entered a strategic partnership that will bring AI-powered stroke care together with leading telestroke neurologists...
Feb 09, 2022
Viz.ai Debuts Viz™ ANX, the First AI-powered Cerebral Aneurysm Detection Solution at SVIN...
Viz.ai is the leader in AI-powered care coordination and has accelerated the time-to-notification of the treatment team by 73 percent...
Nov 17, 2021